written on 09.04.2014

Novartis names two new leaders to growth drivers Alcon, Sandoz


Novartis, amid a company-wide strategic review, has said some of its underperforming units may be on the way out. But as it draws up its blueprints for the future, it's also working to bolster its star businesses, and Wednesday it announced some changes at the top of two of its key divisions.